Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®

作者：James G. Taylor, Sheila Zipfel, Kyla Ramey, Randy Vivian, Adam J. Schrier, Kapil Karki, Ashley A. Katana, Darryl Kato, Tetsuya Kobayashi, Ruben Martinez, Michael Sangi, Dustin S. Siegel, Chinh Van Tran, Zhengyu Yang, Jeff Zablocki, Cheng Yong Yang, Yujin Wang, Kelly Wang, Katie Chan, Ona Barauskas, Guofeng Cheng, Debi Jin, Brian E. Schultz, T.C. Appleby, Armando G. Villaseñor, John O. Link · 发表于：Bioorganic & Medicinal Chemistry Letters · 年份：2019 · DOI：10.1016/j.bmcl.2019.03.037 · 被引用次数：90 · 研究领域：Hepatitis C virus research、HIV/AIDS drug development and treatment、Biochemical and Molecular Research